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Abstract
Pseudomonas aeruginosa is a pathogen that causes acute and chronic infections in a variety of hosts. The pathogenic
potential of P. aeruginosa is strain-dependent. PA14 is a highly virulent strain that causes disease in a wide range of
organisms, whereas PAO1 is moderately virulent. Although PA14 carries pathogenicity islands that are absent in PAO1, the
presence or absence of specific gene clusters is not predictive of virulence. Here, we show that the virulent strain PA14 has
an acquired mutation in the ladS gene. This mutation has a deleterious impact on biofilm, while it results in elevated type III
secretion system (T3SS) activity and increased cytotoxicity towards mammalian cells. These phenotypes can be reverted by
repairing the ladS mutation on the PA14 genome. The RetS/LadS/GacS signaling cascade is associated with virulence and
the switch between acute and chronic infections. RetS is a sensor that down-regulates biofilm formation and up-regulates
the T3SS. Mutations in retS are acquired in strains isolated from chronically infected cystic fibrosis patients and lead to
hyperbiofilm formation and reduced cytotoxicity. Conversely, the LadS sensor promotes biofilm formation and represses the
T3SS. We conclude that the ladS mutation is partly responsible for the high cytotoxicity of PA14, and our findings
corroborate the central role of RetS and LadS in the switch between acute and chronic infections. Given the extensive use of
the reference strain PA14 in infection and virulence models, the bias caused by the ladS mutation on the observed
phenotypes will be crucial to consider in future research.
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Introduction
Pseudomonas aeruginosa is a Gram-negative bacterium that thrives
in a wide range of natural environments, both terrestrial and
aquatic. It is also well known as an opportunistic pathogen with a
broad host range that includes humans. This versatility is reflected
in a relatively large and complex genome, which ranges from 5.1
to 7 Mb in size [1]. The first P. aeruginosa genome to be sequenced
was that of strain PAO1 [2], and one of the striking features was
the high proportion of coding capacity dedicated to regulation
(around 10% of the predicted open reading frames). Unlike strict
human pathogens, selection has therefore favored complexity
rather than specialization in the genome of this species.
P. aeruginosa isolates display a striking variability in virulence,
ranging from very moderate to highly virulent strains [3,4,5].
PAO1, which was isolated from a wound over 50 years ago, is a
moderately virulent strain [6] and belongs to a relatively rare
clonal group. In contrast, the clinical strain PA14 is a highly
virulent isolate and represents the most common clonal group
worldwide [1]. The genome of PA14 was published in 2004 and
revealed a high degree of conservation compared to PAO1 [7].
However, the PA14 genome also contains two pathogenicity
islands that are absent in PAO1, and these carry several genes
implicated in virulence. Examples of this are exoU, which encodes
an effector of the type III secretion system (T3SS), and the Rcs/
Pvr two-component systems that control the cupD fimbrial cluster
[7,8,9]. A recent study has further shown that deletion of one or
both pathogenicity islands impacts the virulence of PA14 in
murine models of acute pneumonia and bacteremia [10]. Despite
this, a study of a series of P. aeruginosa isolates failed to identify any
correlation between PA14-specific genes and the level of virulence
[6]. The presence of specific genes or clusters may therefore not be
predictive of virulence in a given strain.
A large number of infection models have been employed to
assess the pathogenicity of P. aeruginosa during both acute and
chronic infection. The variety of potential hosts is a further
confirmation of the extraordinary versatility of the pathogen. In
addition to mammalian systems, the models include plants (lettuce
leaves and Arabidopsis thaliana), invertebrates (Caenorhabditis elegans),
insects (Galleria mellonella and Drosophila melanogaster) and vertebrates
(zebrafish) [11,12,13]. Although PAO1 is infectious in some of
these models, the majority of them employ PA14, which displays
higher virulence in most hosts [5,14,15].
Some studies have used transposon mutant screens to identify
functions that are required during infection in a certain host
[15,16,17,18,19]. These screens have linked a variety of functions
to virulence, such as chemotaxis, quorum sensing, transcriptional
regulators, multidrug transporter or phenazine production.
Interestingly, some factors appear to be required for full virulence
in a series of different hosts, suggesting that they may play a more
universal role during infection. One of these systems is the GacS/
GacA two-component system, and mutants in the gacS/gacA genes
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models of infection [4,15,20,21].
Of the over 60 two-component systems encoded on the P.
aeruginosa genome [22], the Gac system therefore appears to play a
unique role. The GacS sensor phosphorylates the GacA response
regulator, which promotes transcription of only two genes, namely
the small RNAs (sRNAs) RsmY and RsmZ. These sRNAs relieve
the repression exerted by the post-transcriptional repressor RsmA
on genes that are known to be required for biofilm formation, such
as the pel and psl genes [23,24,25]. Furthermore, the activity of the
GacS/GacA two-component system is inversely regulated by two
additional sensors, RetS and LadS [26,27]. RetS inhibits the
activity of GacS by forming inactive heterodimers, and this
promotes motility and cytotoxicity [28]. Conversely, LadS
activates the GacS/GacA cascade via an unknown mechanism
[27], and this suppresses cytotoxicity while promoting biofilm
formation.
In this study, we show that the PA14 reference strain has a
mutation in the ladS gene, which leaves the protein out of frame.
This mutation results in repression of biofilm formation and
enhanced production of the T3SS, leading to elevated cytotoxicity
in this strain.
Results
P. aeruginosa PA14 has a mutation in the ladS gene
The genomic region encoding the LadS sensor is conserved
across several Pseudomonas species. LadS is a hybrid sensor kinase
with an N-terminal 7TMR-DISMED2 sensing domain, which is
followed by a histidine kinase domain and a receiver domain.
However, an analysis of the PA14 genome [29] revealed that the
ladS open reading frame had not been annotated (http://www.
pseudomonas.com) [30], even though the flanking regions
appeared to be conserved. A detailed investigation of the DNA
sequence (located between 1069280–1071716 nucleotide position
on the genome) showed that the sequence was indeed conserved
(Figure 1A), but that a 49-nucleotide duplication had occurred in
the coding sequence, leading to a frame shift and a gene encoding
a putative truncated protein. The predicted product of the ladS
gene in PA14 has the sensing domain intact, but the gene is out of
frame from codon number 380. From there, a new frame is kept
for an additional 202 codons, resulting in a 581 amino acids-long
protein, with an aberrant C terminus (Figure 1C and Figure S1
panel A). This altered C-terminus did not display any predicted
domain structure or similarity to other known proteins. We
confirmed that the duplication was indeed present in PA14 by
designing primers flanking the insertion site that yielded a 183 bp
product in PAO1 and 232 bp in PA14 (Figure 1B), which suggests
that LadS is not functional in this isolate. The recently updated
Pseudomonas website (http://www.pseudomonas.com) includes four
incomplete P. aeruginosa genomes in addition to the existing four
complete sequences. Apart from PA14, these strains all have an
intact ladS gene resulting in a highly conserved predicted protein
sequence (Figure S1 panel B). We further investigated whether the
PA14 mutation was present in other P. aeruginosa strains by PCR
amplifying the relevant region in four previously published
environmental isolates [6]. However, these strains all appeared
to have an intact ladS gene (Figure S2).
Reconstruction of the ladS gene in PA14 influences
biofilm formation
Apart from the 49 extra nucleotides, the sequence of ladS is
highly conserved between PAO1 and PA14 (Figure 1A). In fact, if
the insertion was to be removed, the resulting PA14 LadS protein
would only have one seemingly neutral amino acid change
(V509A) compared to PAO1. We therefore removed the
duplication by generating a mutator fragment comprising around
1200 bases of ladS sequence amplified from PAO1, which was
cloned into the suicide vector pKNG101. After double crossover
on the PA14 genome, the correction was verified by PCR and
sequencing, generating the strain ladSR. This strain displayed the
same growth rate as PA14 in all conditions tested.
LadS was originally identified in P. aeruginosa PAK as a ‘‘Lost
adherence Sensor’’ [27]. Indeed, a mutation in the ladS gene
resulted in a strain that was unable to form biofilms due to down-
regulation of genes involved in Pel polysaccharide biogenesis. We
therefore tested the ability of PA14-ladSR to form biofilms in
microtiter plates incubated at 37uC with shaking and showed that
the ladSR strain displayed accelerated biofilm formation compared
to PA14 (Figure 2). This delayed attachment phenotype was
verified in glass tubes incubated at 30uC without shaking (Figure 2,
inset). The acquired ladS mutation in PA14 therefore slows down
biofilm formation in this strain, and this can be corrected by
restoring the original frame of the gene.
LadS up-regulates the pel and T6SS genes and down-
regulates the T3SS genes
The RetS/LadS/GacS signaling network converges on the
activity of the post-transcriptional regulator RsmA, the specific
action of which is to bind to and prevent translation of target
mRNAs [23,31,32]. Apart from ladS in PA14, the components of
this signaling cascade are all conserved in the completely
sequenced strains of P. aeruginosa (http://www.pseudomonas.
com). Among the mRNAs that are repressed by RsmA are the
Pel and Psl polysaccharides as well as the T6SS (H1-T6SS) [23],
which has been shown to play an important role in chronic
infection [33,34]. Furthermore, RsmA is known to enhance the
activity of the T3SS, which is involved in cytotoxicity and acute
infection, although the molecular mechanisms of this are currently
unknown. In this context, it is important to note that PA14
displays strain-specific differences, both with respect to polysac-
charide production and the T3SS. While Psl is the primary
polysaccharide in PAO1, Pel plays a more important role in PA14,
which does not have a complete psl gene cluster [35].
Furthermore, the PA14 genome does not encode the type III
effector ExoS, but instead carries the gene encoding the potent
cytotoxin ExoU on the PAPI-2 pathogenicity island [7].
In order to assess the impact of the ladS mutation on target
genes, a qRT-PCR analysis of relevant mRNAs involved in
polysaccharide production, T3S and T6S was carried out on cells
harvested in exponential phase. In these conditions, the pelA
transcript displayed a 60% increase in the ladSR strain compared
to the PA14 (Figure 3). Furthermore, pcrV (T3SS machinery) exoT
and exoU (T3SS effectors) were down-regulated 30–60% compared
to the PA14 wild type. Conversely, hsiA1, which is the first gene in
the H1-T6SS gene cluster [36], and the T6SS substrate tse3 [37],
displayed a 3 and 2-fold increase respectively (Figure 3).
Restoration of the ladS gene in PA14 therefore results in a
modification in the expression profile of the RsmA targets. This
suggests that despite the ladS mutation in PA14, the rest of the
Ret/Gac/Rsm cascade appears fully functional and still able to
respond to LadS signaling.
Restoration of the ladS gene switches the activity of the
T3SS and T6SS
Since the changes observed at the mRNA level were relatively
modest, especially for the T3SS, we investigated whether any
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was carried out using antibodies directed against structural
components of the T3SS [38] and T6SS [39] (PcrV and Hcp1,
respectively). This showed that ladSR produced markedly reduced
levels of PcrV compared to PA14 in standard conditions (Figure 4).
We then investigated whether the T3SS could be induced in the
ladSR strain to the same extent as in the wild type by adding the
chelating agent EGTA to the growth medium. In these conditions,
both strains displayed increased and similar levels of PcrV,
suggesting that induction of the T3SS by EGTA overrules the
repressing effect of LadS.
In order to investigate whether this regulation of the T3SS was
mirrored in the expression of the T6SS, we carried out Western
blots using an antibody directed against the putative structural
component Hcp1 [39]. Previous studies have shown that the T6SS
is not expressed in P. aeruginosa PAK wild type, but that it is
activated in PAKDretS [26]. In agreement with this, we were
unable to detect Hcp1 in PA14 wild type. However, in the ladSR
strain there was a strong induction of the T6SS (Figure 4), which
clearly demonstrates the effect of LadS in the regulation of this
secretion system. It may seem curious that two strains with an
intact ladS gene (PAK wild type and PA14-ladSR) display very
different basal levels of Hcp1. However, studies in our lab have
shown that the production of the T6SS varies substantially
between strains, and this is also known to be the case for the T3SS.
Interestingly, Hcp1 could not be detected in the ladSR strain in
inducing conditions for the T3SS. This observation highlights the
antagonistic regulation of the T3SS and T6SS. It is also worth
noting that the restoration of LadS appeared to have a more
pronounced influence on protein levels than on mRNA levels.
This could be explained by the post-transcriptional activity of
RsmA.
Figure 1. PA14 is a ladS mutant. (A) Alignment of the ladS open reading frame of PAO1 and PA14 starting at +1021 bp. The bold underlined
sequence in PA14 shows the 49 bp duplication, which alters the PA14 reading frame compared to PAO1, illustrated by vertical lines. PCR primers are
indicated by arrows. (B) PCR products of the genomic region indicated in (A), separated by agarose gel electrophoresis. (C) Predicted domain
organization of LadS in PA14 and PAO1. Nonsense protein sequence in PA14 is shown with a dotted line.
doi:10.1371/journal.pone.0029113.g001
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towards mammalian cells
The shift in secretion profile due to the mutation in ladS could
have important implications for the behavior of PA14 during
infection. We therefore tested the cytotoxicity of PA14 and ladSR
in two different models of infection. As previously mentioned, a
PA14::Tn-gacA mutant is attenuated in the commonly used C.
elegans slow killing assay [12,17][40]. However, restoration of ladS
did not alter the C. elegans killing pattern, which was identical to
that of the reference strain (Figure S3). Cytotoxicity was then
monitored by lactate dehydrogenase (LDH) release in HeLa cells.
After one hour of infection, ladSR only displayed around 50% of
the LDH release observed in PA14 (Figure 5). This decrease in
cytotoxicity was likely due to the reduced activity of the T3SS,
since a PA14Tn::pscC transposon mutant [41], which is defective
in T3S, did not display any detectable cytotoxicity in these
conditions. The LDH release in the pscC mutant was comparable
to the E. coli TG1 negative control. These data clearly demonstrate
that the high virulence of P. aeruginosa PA14 can be at least partly
attributed to a hyperactive T3SS due to the absence of a functional
LadS sensor.
Discussion
P. aeruginosa is an environmental bacterium that thrives in a
variety of habitats and is a successful colonizer of a broad range of
hosts, including humans. This unique ability to cope with diverse
environments has been attributed to the large and plastic genome
[42]. Horizontal gene transfer plays an important role in
acquisition of new traits, but is not necessarily accompanied with
the loss of other genes. PA14 carries two pathogenicity islands that
are not present in PAO1 [7]. Intuitively, this could explain the
marked virulence difference between these two strains, but this
seems not to be the case. Indeed, although mutations in PA14
specific genes have been found to attenuate virulence of the strain
[6,7], the presence of the same genes in other isolates could not be
Figure 2. Biofilm formation. Biofilm formation of PA14 and ladSR in
M9 medium. Graph: Biofilm formation in 24-well polystyrene plates at
37uC in shaking conditions. Inset: Crystal violet stained biofilms in glass
tubes after 8 h incubation at 30uC. Data is representative of at least two
independent experiments.
doi:10.1371/journal.pone.0029113.g002
Figure 3. qRT-PCR analysis of target genes in ladSR compared
to PA14. Positive values indicate that mRNA levels are higher in ladSR.
All mRNA levels have been normalized to 16S rRNA.
doi:10.1371/journal.pone.0029113.g003
Figure 4. Immunoblots of PA14 and ladSR cell lysates using
antibodies directed against structural components of the T3SS
and T6SS (PcrV and Hcp1 respectively). The calcium chelator EGTA
was added to the growth medium to induce the T3SS as indicated.
doi:10.1371/journal.pone.0029113.g004
Figure 5. Lactate dehydrogenase (LDH) release of HeLa cells
infected with the indicated bacterial strains for 1 hour. The LDH
release of PA14 has been set to 100%. Data are representative of three
independent experiments. The difference between PA14 and ladSR is
significant with p=0.018.
doi:10.1371/journal.pone.0029113.g005
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subset of genes alone cannot account for the virulence degree of a
particular isolate, variation in transcription and hypermutability
may be critical features for adaptation/evolution in the course of
an infection [43,44,45]. A number of studies have suggested that
microevolution of P. aeruginosa in cystic fibrosis patients is dynamic
and results in a large population diversity with an adaptation, but
not necessarily a loss, of their virulence traits [46,47,48]. Besides
LasR and other components of the quorum sensing systems, the
RetS/LadS/GacS signaling network, which is conserved in most
Pseudomonas species, has been extensively linked to pathogenesis
[49,50]. Mutants in the central two-component system GacS/
GacA are attenuated in multiple models of infection [4,20,21,51],
suggesting a general role in virulence. The GacA response
regulator has only two known targets, namely the sRNAs RsmY
and RsmZ [28]. These RNAs sequester the translational repressor
RsmA, which has proven to be crucial in the switch between
cytotoxicity and biofilm formation, as well as between chronic and
acute infections. Direct targets of RsmA repression include the pel
and psl genes involved in biofilm formation, and the T6SS, which
is important during chronic infection. Conversely, the T3SS is
positively regulated by RsmA, probably in an indirect manner
[23]. The activity of the Gac/Rsm signaling cascade is inversely
controlled by the orphan sensors RetS and LadS [26,27]. A retS
mutant is a hyperbiofilm former that displays low cytotoxicity,
while a ladS mutant displays low levels of biofilm formation and
enhanced cytotoxicity. The significance of this regulatory network
is further confirmed by the recent identification of key adaptive
mutations in the retS gene during chronic infection of CF airways
[52]. A retS mutant displays a hyperbiofilm phenotype and a
reduced cytotoxicity [26]. In this particular case, it seems that a
reduction of virulence of the strain could be associated with
adaptation to chronic infection in CF patients.
In this study, we show that the hyper-virulent strain PA14 is a
ladS mutant. The observed duplication in the ladS open reading
frame may be the result of DNA repair following a double
stranded break, which leaves the protein truncated and out of
frame. This is likely to be a relatively recent event, given the
absence of secondary mutations in the gene. The impact of the
mutation was evaluated by restoring the native gene on the
chromosome, generating ladSR. The restored strain displayed
enhanced biofilm formation, increased expression of the T6SS,
and reduced expression of the T3SS. Importantly, expression of
the T3SS effector coded by the exoU gene that is located on the
pathogenicity island PAPI-2 is controlled by the core genome-
encoded LadS sensor. These changes were observed at the
transcriptional, as well as on the protein or phenotypic level.
Furthermore, the change in the T3SS translated into reduced
cytotoxicity, as evaluated by LDH release in HeLa cells.
Conversely, no difference was observed in a C. elegans slow killing
assay, which has been shown to be independent of the T3SS [53].
Mutations leading to reduced virulence are more commonly
reported than mutations leading to hypervirulence. This could be
partly because many infection models have primarily been
developed to screen for attenuation of virulence. The identification
of a ladS mutation in the hyper-virulent burn wound isolate PA14,
combined with the fact that it is the only sequenced P. aeruginosa
strain that lacks a functional psl polysaccharide biosynthetic cluster
[54], suggest that PA14 behavior during infection may not be
representative of other members of the species. Given that the vast
majority of virulence and cytotoxicity studies have been carried
out using either PA14 or PAO1, it is crucial to take into account
that the PA14 isolate is a ladS mutant and that this mutation has
marked consequences on its pathogenesis.
Materials and Methods
Strains and growth conditions
Unless otherwise stated, cultures were grown in LB at 37uC with
shaking. Primers used in this study are listed in Table S1. The ladS
duplication in PA14 was verified using primers ladSF and ladSR.
The PA14-ladSR strain was generated as follows. A 1 200 bp
region of the ladS gene was amplified by PCR from PAO1
genomic DNA using primers ladS1 and ladS2. The product was
cloned into pCR2.1-TA and sequenced, then sub-cloned into the
P. aeruginosa suicide vector pKNG101. After sucrose selection,
restored clones were identified using primers ladSF and ladSR,
and the crossover was confirmed by sequencing of the 1 200 bp
mutator region.
Biofilm formation
Attachment assays were carried out in 24-well polystyrene
plates. Overnight cultures were inoculated into M9 medium with
glucose to a final O.D600 nm of 0.1 and incubated at 37uC with
shaking. Attached cells were stained with 0.1% crystal violet (CV)
at the indicated time points. Unbound dye was removed by
washing twice with water, the CV was dissolved in 96% ethanol
and absorbance was monitored at 600 nm. Visualization of
biofilms was carried out in M9 medium in glass tubes that were
incubated at 30uC without shaking and stained with crystal violet
as described above.
qRT-PCR. Overnight cultures were sub-cultured into LB,
grown to exponential phase (O.D600 nm 1) and harvested into
RNAlater (Ambion). RNA extraction, reverse transcription and
qPCR was carried out as previously described [55]. Gene
expression was normalized to 16S rRNA.
Immunoblotting
For Western analysis, cultures were inoculated into LB medium
to O.D600 nm 0.1 and incubated at 37uC with shaking for 5 hours.
Induction of the T3SS was achieved by adding EGTA (5 mM) and
MgCl2 (20 mM) to the growth medium. Whole cell lysates were
separated by SDS-PAGE. Primary antibodies, a-Hcp1 [56] and a-
PcrV (kindly provided by A. Rietsch) were used at dilutions of
1:5 000 and 1:10 000 respectively. Secondary antibody (horserad-
ish peroxidise-conjugated goat anti-rabbit IgG, Sigma) was used at
1:5 000 dilution. Visualization was achieved using the SuperSignal
West Pico Chemiluminescent Substrate Kit (Thermo) and a
LAS3000 Imaging System (Fuji).
Lactate dehydrogenase (LDH) release assay
The cytotoxicity of PA14 and PA14-ladSR was assessed using
HeLa cells (ATCC CCL-2) using E. coli TG1 and PA14Tn::pscC
(PA14Tn::PA14_42350) [41], which is defective in T3S, as
negative controls. HeLa cells were routinely maintained in
Dulbecco’s Modified Eagle’s Medium with 1 000 mg/L glucose
(Sigma), supplemented with FBS, non-essential amino acids and
GlutaMAX (Invitrogen). Cytotoxicity assays were carried out on
confluent cells in 96-well plates. Prior to infection, cells were
washed twice in PBS, and the medium was changed to RPMI
1640 without phenol red (Invitrogen). Bacterial strains were sub-
cultured from overnight cultures into LB to a final OD600 nm of 0.1
and grown at 37uC with shaking for 2 hours. Cells were then
harvested, washed twice in PBS and resuspended in RPMI 1640
medium. HeLa cells were infected with an initial multiplicity of
infection of 20, and the infection was synchronized by centrifu-
gation for 5 minutes at 1 000 g. After incubation for 1 hour at
37uCi n5 %C O 2, LDH release was assayed using the CytoTox 96
Assay Kit (Promega) following the supplier’s instructions.
The P. aeruginosa PA14 Strain Is a ladS Mutant
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Figure S1 Alignment of predicted protein sequences of LadS in
various strains of P. aeruginosa (MultAlin, Corpet et al. 1988). A)
PAO1 vs. PA14. B) Seven P. aeruginosa strains available in the
Pseudomonas database (Winsor et al. 2011). Supplementary
reference Corpet F (1988): Multiple sequence alignment with
hierarchical clustering. Nucl. Acids Res. 16(22), 10881–10890.
(PPTX)
Figure S2 PCR of a section of the ladS gene in PAO1, PA14 and
four environmental isolates (Lee et al. 2006) as indicated using
primers ladSF and ladSR (Table S1).
(PPTX)
Figure S3 C. elegans slow killing assay. L4 larvae were transferred
onto lawns of PA14 or ladSR as previously described (Powell &
Ausubel, 2008), and viability was scored at the indicated time
points. Data is representative of three independent experiments.
(PPTX)
Table S1 Oligonucleotides used in this study.
(DOCX)
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